Worldwide Study Finder

Loading registry information…

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:54 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4CompletedINTERVENTIONAL

Rapid Activity of Platelet Inhibitor Drugs Study 2

ClinicalTrials.gov · NCT01805570 · Registry updated: 2014-09-25

Condition / research focus: Myocardial Infarction
Sponsor: David Antoniucci
Countries with listed sites: Italy
Registry dates and results: Start: 2012-11. Completion: 2013-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Prasugrel (drug)
Ticagrelor (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Careggi Hospital
Florence, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Phase 4CompletedINTERVENTIONAL

Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome

ClinicalTrials.gov · NCT00373451 · Registry updated: 2012-05-08

Condition / research focus: Myocardial Infarction; Coronary Disease
Sponsor: Deutsches Herzzentrum Muenchen
Countries with listed sites: Germany · Italy
Registry dates and results: Start: 2006-07. Completion: 2011-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Abciximab + UFH (drug) — also listed as: ReoPro
Bivalirudin (drug) — also listed as: Angiox
Heparin (drug) — also listed as: unfractionated heparin

Where the study takes place — 9 listed sites

Herz-Zentrum Bad Krozingen
Bad Krozingen, Germany
Site recruitment: Not reported
Herz- und Gefaessklinik, Kardiologie
Bad Neustadt an der Saale, Germany
Site recruitment: Not reported
Vivantes Klinikum im Friedrichshain
Berlin, Germany
Site recruitment: Not reported
Vivantes Auguste Viktoria Klinikum
Berlin, Germany
Site recruitment: Not reported
Vivantes Klinikum Neukoelln
Berlin, Germany
Site recruitment: Not reported
Deutsches Herzzentrum Muenchen
Munich, Germany
Site recruitment: Not reported
Medizinische Klinik, Klinikum rechts der Isar
München, Germany
Site recruitment: Not reported
Marienhospital Osnabrueck
Osnabrück, Germany
Site recruitment: Not reported
Ospedale Cageggi
Florence, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

Rapid Activity of Platelet Inhibitor Drugs Study 2

Explore the world’s study registries

Worldwide

Africa

Americas

A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin)

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients

Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction

The MATRIX OCT Substudy

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI

Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin

Phase 1 Single Dose Escalation Study of CTB-001

Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome

ImproveR International (BI-001-IM)

RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)

Outpatient Percutaneous Coronary Intervention

Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial

Utilisation of Angiox® in European Practice

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

Bivalirudin as a Procedural Anticoagulant in Pediatrics

Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance

Asia

Middle East

Europe

Oceania